Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria

American Journal of Tropical Medicine and Hygiene

Volumn 87, Issue 1, 2012, Pages 35-40

  Adam, Ishag ^a   Tarning, Joel ^b   Lindegardh, Niklas ^b   Mahgoub, Hyder ^c   McGready, Rose ^d   Nosten, François ^d  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c New Hafa Teaching Hospital   (Sudan)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE;

ABDOMINAL PAIN; ADULT; ANOREXIA; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EXPOSURE; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALARIA FALCIPARUM; MASS SPECTROMETRY; NAUSEA AND VOMITING; PLASMA; PREGNANT WOMAN; PRURITUS; RASH; SIDE EFFECT; SKIN PIGMENTATION; SUDAN; TIME TO MAXIMUM PLASMA CONCENTRATION; TINNITUS; VENOUS BLOOD;

ADULT; ANTIMALARIALS; AREA UNDER CURVE; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MALARIA, FALCIPARUM; MASS SPECTROMETRY; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; QUINOLINES; SUDAN; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM;

EID: 84863762181     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.11-0410     Document Type: Article

References (39)

1. Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO, 2010. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med 7: e1000221.
2. Elghazali G, Adam I, Hamad A, El-Bashir MI, 2003. Plasmodium falciparum infection during pregnancy in an unstable transmission area in eastern Sudan. East Mediterr Health J 9: 570-580. (Pubitemid 40485295)
3. Luxemburger C, Ricci F, Nosten F, Raimond D, Bathet S, White NJ, 1997. The epidemiology of severe malaria in an area of low transmission in Thailand. Trans R Soc Trop Med Hyg 91: 256-262. (Pubitemid 27261158)
4. Adam I, Babiker S, Mohmmed AA, Salih MM, Prins MH, Zaki ZM, 2007. ABO blood group system and placental malaria in an area of unstable malaria transmission in eastern Sudan. Malar J 6: 110.
5. Adam I, Khamis AH, Elbashir MI, 2005. Prevalence and risk factors for anemia in pregnant women of eastern Sudan. Trans R Soc Trop Med Hyg 99: 739-743. (Pubitemid 41150670)
6. Adam I, Khamis AH, Elbashir MI, 2005. Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women of eastern Sudan. Malar J 4: 18.
7. Bader E, Alhaj AM, Hussan AA, Adam I, 2010. Malaria and stillbirth in OmdurmanMaternity Hospital, Sudan. Int J Gynaecol Obstet 109: 144-146.
8. Brabin BJ, 1983. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 61: 1005-1016. (Pubitemid 14181621)
9. Elhassan EM, Mirghani OA, Adam I, 2009. High maternal mortality and stillbirth in the Wad Medani Hospital, Central Sudan, 2003-2007. Trop Doct 39: 238-239.
10. Haggaz AA, Radi EA, Adam I, 2007. High maternal mortality in Darfur, Sudan. Int J Gynaecol Obstet 98: 252-253. (Pubitemid 47210999)
11. World Health Organization, 2010. Guidelines for the Treatment of Malaria. Geneva: World Health Organization.
12. Adam I, Osman ME, Elghzali G, Ahmed GI, Gustafssons LL, Elbashir MI, 2004. Efficacies of chloroquine, sulfadoxinepyrimethamine and quinine in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan. Ann Trop Med Parasitol 98: 661-666. (Pubitemid 39390069)
13. Adam I, Salah MT, Eltahir HG, Elhassan AH, Elmardi KA, Malik EM, 2010. Dihydroartemisinin-piperaquine versus artemetherlumefantrine, in the treatment of uncomplicated Plasmodium falciparum malaria in central Sudan. Ann Trop Med Parasitol 104: 319-326.
14. Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung RM, Laihad F, Ebsworth EP, Anstey NM, Tjitra E, Price RN, 2007. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet 369: 757-765. (Pubitemid 46335820)
15. Loebstein R, Lalkin A, Koren G, 1997. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 33: 328-343. (Pubitemid 27480937)
16. Ohkita C, Goto M, 1990. Increased 6-hydroxycortisol excretion in pregnant women: implication of drug-metabolizing enzyme induction. DICP 24: 814-816. (Pubitemid 20280651)
17. Tarning J,McGready R, Lindegardh N, Ashley EA, Pimanpanarak M, Kamanikom B, Annerberg A, Day NP, Stepniewska K, Singhasivanon P, White NJ, Nosten F, 2009. Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria. Antimicrob Agents Chemother 53: 3837-3846.
18. Nyunt MM, Adam I, Kayentao K, van Dijk J, Thuma P, Mauff K, Little F, Cassam Y, Guirou E, Traore B, Doumbo O, Sullivan D, Smith P, Barnes KI, 2010. Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy. Clin Pharmacol Ther 87: 226-234.
19. McGready R, Stepniewska K, Ward SA, Cho T, Gilveray G, Looareesuwan S, White NJ, Nosten F, 2006. Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria. Eur J Clin Pharmacol 62: 367-371.
20. McGready R, Stepniewska K, Edstein MD, Cho T, Gilveray G, Looareesuwan S, White NJ, Nosten F, 2003. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria. Eur J Clin Pharmacol 59: 545-552. (Pubitemid 37368905)
21. Karunajeewa HA, Salman S, Mueller I, Baiwog F, Gomorrai S, Law I, Page-Sharp M, Rogerson S, Siba P, Ilett KF, Davis TM, 2010. Pharmacokinetics of chloroquine and monodesethylchloroquine in pregnancy. Antimicrob Agents Chemother 54: 1186-1192.
22. Karunajeewa HA, Salman S, Mueller I, Baiwog F, Gomorrai S, Law I, Page-Sharp M, Rogerson S, Siba P, Ilett KF, Davis TM, 2009. Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women. Antimicrob Agents Chemother 53: 4368-4376.
23. World Health Organization, 2000. Severe falciparum malaria. Trans R Soc Trop Med Hyg 94: 1-90.
24. Lindegardh N, Annerberg A, White NJ, Day NP, 2008. Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects. J Chromatogr B Analyt Technol Biomed Life Sci 862: 227-236.
25. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE, 1995. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg 52: 565-568.
26. Tarning J, Lindegardh N, Annerberg A, Singtoroj T, Day NP, Ashton M, White NJ, 2005. Pitfalls in estimating piperaquine elimination. Antimicrob Agents Chemother 49: 5127-5128. (Pubitemid 41778931)
27. Tarning J, Ashley EA, Lindegardh N, Stepniewska K, Phaiphun L, Day NP, McGready R, Ashton M, Nosten F, White NJ, 2008. Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisininpiperaquine in patients with Plasmodium falciparum malaria in Thailand. Antimicrob Agents Chemother 52: 1052-1061. (Pubitemid 351358388)
28. Karunajeewa HA, Ilett KF, Mueller I, Siba P, Law I, Page-Sharp M, Lin E, Lammey J, Batty KT, Davis TM, 2008. Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria. Antimicrob Agents Chemother 52: 237-243.
29. Hung TY, Davis TM, Ilett KF, Karunajeewa H, Hewitt S, Denis MB, Lim C, Socheat D, 2004. Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria. Br J Clin Pharmacol 57: 253-262. (Pubitemid 38296988)
30. Rijken MJ, McGready R, Boel ME, Barends M, Proux S, Pimanpanarak M, Singhasivanon P, Nosten F, 2008. Dihydroartemisinin-piperaquine rescue treatment of multidrugresistant Plasmodium falciparum malaria in pregnancy: a preliminary report. Am J Trop Med Hyg 78: 543-545. (Pubitemid 351845153)
31. Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Warikar N, Seal A, McGready R, Sugiarto P, Tjitra E, Anstey NM, Price RN, 2008. Adverse pregnancy outcomes in an area where multidrug-resistant Plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis 46: 1374-1381. (Pubitemid 351589936)
32. Poespoprodjo JR, Fobia W, Kenangalem E, Hasanuddin A, Sugiarto P, Tjitra E, Anstey NM, Price RN, 2011. Highly effective therapy for maternal malaria associated with a lower risk of vertical transmission. J Infect Dis 204: 1613-1619.
33. Batty KT, Moore BR, Stirling V, Ilett KF, Page-Sharp M, Shilkin KB, Mueller I, Rogerson SJ, Karunajeewa HA, Davis TM, 2010. Investigation of reproductive toxicity of piperaquine in mice. Reprod Toxicol 29: 206-213.
34. Morris CA, Onyamboko MA, Capparelli E, Koch MA, Atibu J, Lokomba V, Douoguih M, Hemingway-Foday J, Wesche D, Ryder RW, Bose C, Wright L, Tshefu AK, Meshnick S, Fleckenstein L, 2011. Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria. Malar J 10: 114.
35. Tarning J, Rijken MJ, McGready R, Phyo AP, Hanpithakpong W, Day NP, White NJ, Nosten F, Lindegardh N, 2012. Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria. Antimicrob Agents Chemother 56: 1997-2007.
36. Roshammar D, Hai TN, Friberg Hietala S, Van Huong N, Ashton M, 2006. Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects. Eur J Clin Pharmacol 62: 335-341.
37. Sim IK, Davis TM, Ilett KF, 2005. Effects of a high-fat meal on the relative oral bioavailability of piperaquine. Antimicrob Agents Chemother 49: 2407-2411. (Pubitemid 40734473)
38. Nguyen TC,NguyenNQ,NguyenXT, BuiD, Travers T,Edstein MD, 2008. Pharmacokinetics of the antimalarial drug piperaquine in healthy Vietnamese subjects. Am J Trop Med Hyg 79: 620-623.
39. Chinh NT, Quang NN, Thanh NX, Dai B, Geue JP, Addison RS, Travers T, Edstein MD, 2009. Pharmacokinetics and bioequivalence evaluation of two fixed-dose tablet formulations of dihydroartemisinin and piperaquine in Vietnamese subjects. Antimicrob Agents Chemother 53: 828-831.